Neurology - Medicine.net

Alzheimer's discovery reveals dire effect of toxic tau protein

by Josh Barney,University of VirginiaTau proteins are prime suspects in Alzheimer’s and other neurodegenerative disorders. New UVA research could open doors to future treatments. Credit: Emily F

Updated on: December 28,2023

Alzheimer's discovery reveals dire effect of toxic tau protein

by Josh Barney,University of VirginiaTau proteins are prime suspects in Alzheimer’s and other neurodegenerative disorders. New UVA research could open doors to future treatments. Credit: Emily F

Updated on:December 28,2023

New study sheds light on how our brains perceive—or fail to perceive—what we see

byAllen Institute for Brain ScienceCredit: Magoi from PexelsA newstudyinNature Neuroscienceon 'visual masking' sheds light on how we 'unsee' things and po

Updated on: January 10,2024

New study sheds light on how our brains perceive—or fail to perceive—what we see

byAllen Institute for Brain ScienceCredit: Magoi from PexelsA newstudyinNature Neuroscienceon 'visual masking' sheds light on how we 'unsee' things and po

Updated on:January 10,2024

Researchers discover a protein that stimulates optic nerve regeneration

by Kim Krieger,University of ConnecticutThe image on the left (A) shows four optic nerves that have been crushed. Live nerve tissue glows green in this image, while damaged nerve tissue is dark.

Updated on: March 28,2024

Researchers discover a protein that stimulates optic nerve regeneration

by Kim Krieger,University of ConnecticutThe image on the left (A) shows four optic nerves that have been crushed. Live nerve tissue glows green in this image, while damaged nerve tissue is dark.

Updated on:March 28,2024

Can targeted therapies be applied to patients with Alzheimer's?

by Joe Lafata,University of UtahTara Mastren, center, is leading research into developing targeted alpha-particle therapies for patients with Alzheimer's. The University of Utah professor of

Updated on: August 26,2024

Can targeted therapies be applied to patients with Alzheimer's?

by Joe Lafata,University of UtahTara Mastren, center, is leading research into developing targeted alpha-particle therapies for patients with Alzheimer's. The University of Utah professor of

Updated on:August 26,2024

More parallel 'traffic' observed in human brains than in animals

by Celia Luterbacher,Ecole Polytechnique Federale de LausanneIn the mouse and macaque brains, information was sent along a single "road", while in humans, there were multiple parallel

Updated on: December 30,2023

More parallel 'traffic' observed in human brains than in animals

by Celia Luterbacher,Ecole Polytechnique Federale de LausanneIn the mouse and macaque brains, information was sent along a single "road", while in humans, there were multiple parallel

Updated on:December 30,2023

Brain implants could restore paralyzed patients' arm movements

by Lucie AUBOURGThe Dutch company Onward developed a device that takes signals from a brain implant and uses them to stimulate a paralyzed patient's spinal cord, thus restoring lost movement.A par

Updated on: January 07,2024

Brain implants could restore paralyzed patients' arm movements

by Lucie AUBOURGThe Dutch company Onward developed a device that takes signals from a brain implant and uses them to stimulate a paralyzed patient's spinal cord, thus restoring lost movement.A par

Updated on:January 07,2024

Scientists identify a key driver of myelin repair

by Nicholas Weiler,Stanford UniversityActin filaments (cyan) and an actin regulatory protein (magenta) in a differentiating oligodendrocyte. Credit: Brad Zuchero and Andrew OlsonNew research fro

Updated on: March 27,2024

Scientists identify a key driver of myelin repair

by Nicholas Weiler,Stanford UniversityActin filaments (cyan) and an actin regulatory protein (magenta) in a differentiating oligodendrocyte. Credit: Brad Zuchero and Andrew OlsonNew research fro

Updated on:March 27,2024

More than half a million global stroke deaths may be tied to climate change

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainA changing climate may be linked to growing death and disability from stroke in regions around the world, according to a study pu

Updated on: April 28,2024

More than half a million global stroke deaths may be tied to climate change

byAmerican Academy of NeurologyCredit: Unsplash/CC0 Public DomainA changing climate may be linked to growing death and disability from stroke in regions around the world, according to a study pu

Updated on:April 28,2024

Unawareness of memory decline tied to higher risk for progression

by Lori SolomonUnawareness, rather than heightened awareness, of memory decline is strongly associated with future clinical progression in older adults, according to a study published online April 25

Updated on: May 26,2024

Unawareness of memory decline tied to higher risk for progression

by Lori SolomonUnawareness, rather than heightened awareness, of memory decline is strongly associated with future clinical progression in older adults, according to a study published online April 25

Updated on:May 26,2024

Arterial connections found to improve treatment outcomes following stroke

by Kurt Bodenmüller,University of ZurichVisualization of the blood vessels in the brain of a patient without early venous filling Credit: P. Thurner und Z. Kulcsar, University Hospital ZurichBlo

Updated on: April 09,2024

Arterial connections found to improve treatment outcomes following stroke

by Kurt Bodenmüller,University of ZurichVisualization of the blood vessels in the brain of a patient without early venous filling Credit: P. Thurner und Z. Kulcsar, University Hospital ZurichBlo

Updated on:April 09,2024

First gene therapy for children with metachromatic leukodystrophy approved by FDA

by Lori SolomonThe U.S. Food and Drug Administration has approved Orchard Therapeutics' Lenmeldy (atidarsagene autotemcel) as the first gene therapy for the treatment of children with metachromati